Vol. 151, No. 4 — February 22, 2017
Registration
SOR/2017-13 February 3, 2017
CONTROLLED DRUGS AND SUBSTANCES ACT
Order Amending Schedules I, III and IV to the Controlled Drugs and Substances Act
P.C. 2017-83 February 3, 2017
His Excellency the Governor General in Council, on the recommendation of the Minister of Health, pursuant to section 60 of the Controlled Drugs and Substances Act (see footnote a), deeming that it is necessary in the public interest, makes the annexed Order Amending Schedules I, III and IV to the Controlled Drugs and Substances Act.
Order Amending Schedules I, III and IV to the Controlled Drugs and Substances Act
Amendments
1 Subitems 1(32) to (36) of Schedule I to the Controlled Drugs and Substances Act (see footnote 1) are replaced by the following:
- (32) Apomorphine (5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol) and its salts
- (33) Cyprenorphine (N-(cyclopropylmethyl)-6,7,8,14-tetrahydro-7α-(1-hydroxy-1-methylethyl)-6,14-endo-ethenonororipavine) and its salts
- (34) Nalmefene (17-(cyclopropylmethyl)-4,5α-epoxy-6-methylenemorphinan-3,14-diol) and its salts
- (34.1) Naloxone (4,5α-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one) and its salts
- (34.2) Naltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one) and its salts
- (34.3) Methylnaltrexone (17-(cyclopropylmethyl)4,5α-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium) and its salts
- (34.4) Naloxegol (4,5α-epoxy-6α-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propenyl)morphinan-3,14-diol) and its salts
- (35) Narcotine (6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3-dioxolo [4,5-g]isoquinolin-5-yl)-1(3H)-isobenzofuranone) and its salts
- (36) Papaverine (1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline) and its salts
2 Subitems 3(23) and (24) of Schedule I to the Act are replaced by the following:
- (23) Carperidine (ethyl 1-(2-carbamylethyl)-4-phenylpiperidine-4-carboxylate) and its salts
- (24) Oxpheneridine (ethyl 1-(2-hydroxy-2-phenylethyl)-4-phenylpiperidine-4-carboxylate) and its salts
3 Subitems 4(2) to (4) of Schedule I to the Act are replaced by the following:
- (2) Ethoheptazine (ethyl hexahydro-1-methyl-4-phenylazepine-4-carboxylate) and its salts
- (3) Metethoheptazine (ethyl hexahydro-1,3-dimethyl-4-phenylazepine-4-carboxylate) and its salts
- (4) Metheptazine (methylhexahydro-1,2-dimethyl-4-phenylazepine-4-carboxylate) and its salts
4 Subitems 10(10) to (15) of Schedule I to the Act are replaced by the following:
- (10) Dextromethorphan (d-1,2,3,9,10, 10a-hexahydro-6-methoxy-11-methyl-4H-10,4a-iminoethanophenanthren) and its salts
- (11) Dextrorphan (d-1,2,3,9,10,10a-hexahydro-11-methyl-4H-10,4a-iminoethanophenanthren-6-ol) and its salts
- (12) Levallorphan (l-11-allyl-1,2,3,9,10,10a-hexahydro-4H-10,4a-iminoethanophenanthren-6-ol) and its salts
- (13) Levargorphan (l-11-propargyl-1,2,3,9,10,10a-hexahydro-4H-10,4a-iminoethanophenanthren-6-ol) and its salts
- (14) Butorphanol (l-N-cyclobutylmethyl-3,14-dihydroxymorphinan) and its salts
- (15) Nalbuphine (N-cyclobutylmethyl-4,5-epoxy-morphinan-3,6,14-triol) and its salts
5 Subitem 11(4) of Schedule I to the Act is replaced by the following:
- (4) Cyclazocine (1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(cyclopropylmethyl)-2,6-methano-3-benzazocin-8-ol) and its salts
6 Item 19 of Schedule III to the Act is replaced by the following:
- 19 Cathinone ((-)-α-aminopropiophenone) and its salts
7 (1) Subitem 1(6) of Schedule IV to the Act is repealed.
(2) Item 1 of Schedule IV to the Act is amended by adding the following after subitem (28):
- but not including
- (29) Barbituric Acid (2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts
- (30) 1,3-dimethylbarbituric acid (1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts
8 Item 7 of Schedule IV to the Act is replaced by the following:
- 7 Pipradrol (α,α-diphenyl-2-piperidinemethanol) and its salts
9 Item 9 of Schedule IV to the Act is replaced by the following:
- 9 Butorphanol (l-N-cyclobutylmethyl-3,14-dihydroxymorphinan) and its salts
10 Item 10 of Schedule IV to the English version of the Act is replaced by the following:
- 10 Nalbuphine (N-cyclobutylmethyl-4,5-epoxy-morphinan-3,6,14-triol) and its salts
11 Item 18 of Schedule IV to the Act is amended by adding the following after subitem (34):
- (35) Clozapine N-oxide (8-chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) and its salts
12 The portion of Item 19 of Schedule IV to the Act before subitem (1) is replaced by the following:
- 19 Catha edulis Forsk, its preparations, derivatives, alkaloids and salts, including:
Coming into Force
13 This Order comes into force on the day on which it is published in the Canada Gazette, Part II.
N.B. The Regulatory Impact Analysis Statement for this Order appears following SOR/2017-12, Regulations Amending Certain Regulations Made Under the Controlled Drugs and Substances Act.
- Footnote a
S.C. 1996, c. 19 - Footnote 1
S.C. 1996, c. 19